Evaluation of Different Tandem MS Acquisition Modes to Support Metabolite Annotation in Human Plasma Using Ultra High-Performance Liquid Chromatography High-Resolution Mass Spectrometry for Untargeted Metabolomics.

high-resolution mass spectrometry human plasma ion mobility mass spectrometry metabolite annotation metabolomics tandem mass spectrometry ultra-high performance liquid chromatography

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
15 Nov 2020
Historique:
received: 23 09 2020
revised: 23 10 2020
accepted: 09 11 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 19 11 2020
Statut: epublish

Résumé

Ultra-high performance liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) is a powerful and essential technique for metabolite annotation in untargeted metabolomic applications. The aim of this study was to evaluate the performance of diverse tandem MS (MS/MS) acquisition modes, i.e., all ion fragmentation (AIF) and data-dependent analysis (DDA), with and without ion mobility spectrometry (IM), to annotate metabolites in human plasma. The influence of the LC separation was also evaluated by comparing the performance of MS/MS acquisition in combination with three complementary chromatographic separation modes: reversed-phase chromatography (RPLC) and hydrophilic interaction chromatography (HILIC) with either an amide (aHILIC) or a zwitterionic (zHILIC) stationary phase. RPLC conditions were first chosen to investigate all the tandem MS modes, and we found out that DDA did not provide a significant additional amount of chemical coverage and that cleaner MS/MS spectra can be obtained by performing AIF acquisitions in combination with IM. Finally, we were able to annotate 338 unique metabolites and demonstrated that zHILIC was a powerful complementary approach to both the RPLC and aHILIC chromatographic modes. Moreover, a better analytical throughput was reached for an almost negligible loss of metabolite coverage when IM-AIF and AIF using ramped instead of fixed collision energies were used.

Identifiants

pubmed: 33203160
pii: metabo10110464
doi: 10.3390/metabo10110464
pmc: PMC7697060
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Anal Chem. 2018 Sep 18;90(18):10758-10764
pubmed: 30096227
Mass Spectrom Rev. 2019 May;38(3):291-320
pubmed: 30707468
Metabolites. 2020 Apr 18;10(4):
pubmed: 32325648
Curr Opin Biotechnol. 2015 Aug;34:1-8
pubmed: 25461505
Anal Chem. 2014 Jan 21;86(2):1202-9
pubmed: 24383719
Metabolites. 2018 May 10;8(2):
pubmed: 29748461
Nat Methods. 2018 Sep;15(9):681-684
pubmed: 30150755
Anal Chim Acta. 2020 Feb 22;1099:26-38
pubmed: 31986274
J Am Soc Mass Spectrom. 1994 Sep;5(9):859-66
pubmed: 24222034
Anal Chem. 2020 Apr 7;92(7):5013-5022
pubmed: 32167758
J Am Soc Mass Spectrom. 2017 Apr;28(4):709-723
pubmed: 28116700
Rapid Commun Mass Spectrom. 2019 Jul;33 Suppl 2:66-74
pubmed: 30801790
J Mass Spectrom. 2010 Jul;45(7):703-14
pubmed: 20623627
J Proteome Res. 2019 Feb 1;18(2):797-802
pubmed: 30574788
Anal Chim Acta. 2016 Apr 15;916:8-16
pubmed: 27016433
Metabolomics. 2018;14(6):72
pubmed: 29805336
Anal Chim Acta. 2018 Dec 11;1037:327-337
pubmed: 30292309
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 15;1116:9-18
pubmed: 30951967
Anal Chem. 2019 Feb 5;91(3):2155-2162
pubmed: 30608141
Rapid Commun Mass Spectrom. 2017 Jul 15;31(13):1147-1157
pubmed: 28455852
J Chromatogr A. 2019 May 10;1592:47-54
pubmed: 30685186
Anal Chem. 2017 Aug 1;89(15):7933-7942
pubmed: 28641411
PLoS One. 2011 Feb 16;6(2):e16957
pubmed: 21359215
Ther Drug Monit. 2005 Dec;27(6):747-51
pubmed: 16404815
J Pharm Biomed Anal. 2014 Jan;87:1-11
pubmed: 24091079
Electrophoresis. 2020 Aug 3;:
pubmed: 32744343
Rapid Commun Mass Spectrom. 2017 Jan 15;31(1):33-38
pubmed: 27760459
Anal Chem. 2014 Apr 15;86(8):3985-93
pubmed: 24640936
Rapid Commun Mass Spectrom. 2006;20(13):1989-94
pubmed: 16755610
Anal Chim Acta. 2020 Apr 8;1105:28-44
pubmed: 32138924
Nat Protoc. 2017 Apr;12(4):797-813
pubmed: 28301461
J Chromatogr A. 2017 Dec 1;1526:1-12
pubmed: 29074071
J Sep Sci. 2018 Jan;41(1):20-67
pubmed: 29024509
Metabolites. 2019 Sep 20;9(10):
pubmed: 31547088
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Anal Chem. 2019 Nov 19;91(22):14407-14416
pubmed: 31638379
Metabolites. 2019 Nov 27;9(12):
pubmed: 31783638
Nat Biotechnol. 2016 Aug 9;34(8):828-837
pubmed: 27504778
Mass Spectrom Rev. 2019 May;38(3):221-238
pubmed: 29073341
J Nutr. 2019 Jun 1;149(6):915-922
pubmed: 31049566
Curr Opin Chem Biol. 2018 Feb;42:9-15
pubmed: 29107931
Anal Chem. 2019 Jul 2;91(13):8025-8035
pubmed: 31074960
Alzheimers Res Ther. 2019 Nov 28;11(1):93
pubmed: 31779690
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165690
pubmed: 31962175
J Chromatogr A. 2018 Mar 23;1542:82-88
pubmed: 29472071
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jul 1;1120:62-70
pubmed: 31071580
J Proteome Res. 2020 May 1;19(5):2053-2070
pubmed: 32285670
Anal Chim Acta. 2018 Nov 22;1032:178-187
pubmed: 30143215
Anal Chem. 2018 Apr 3;90(7):4616-4625
pubmed: 29528626
J Pharm Biomed Anal. 2018 Nov 30;161:313-325
pubmed: 30195171
Clin Chem. 2018 Aug;64(8):1158-1182
pubmed: 29921725
J Chromatogr A. 2018 Aug 10;1562:96-107
pubmed: 29861304
Anal Bioanal Chem. 2016 Sep;408(22):6079-91
pubmed: 27370688

Auteurs

Julian Pezzatti (J)

School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva 4, Switzerland.

Víctor González-Ruiz (V)

School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva 4, Switzerland.
Swiss Centre for Applied Human Toxicology (SCATH), 4055 Basel, Switzerland.

Julien Boccard (J)

School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva 4, Switzerland.
Swiss Centre for Applied Human Toxicology (SCATH), 4055 Basel, Switzerland.

Davy Guillarme (D)

School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva 4, Switzerland.

Serge Rudaz (S)

School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva 4, Switzerland.
Swiss Centre for Applied Human Toxicology (SCATH), 4055 Basel, Switzerland.

Classifications MeSH